1. Zhao, Gang, Yuan, Hang, Li, Qin, Li, Kai, Lin, Ping. 2022. DDX39B drives colorectal cancer progression by promoting the stability and nuclear translocation of PKM2. In Signal transduction and targeted therapy, 7, 275. doi:10.1038/s41392-022-01096-7. https://pubmed.ncbi.nlm.nih.gov/35973989/
2. Cargill, Michael, Venkataraman, Rasika, Lee, Stanley. 2021. DEAD-Box RNA Helicases and Genome Stability. In Genes, 12, . doi:10.3390/genes12101471. https://pubmed.ncbi.nlm.nih.gov/34680866/
3. Roth, Jonathan F, Braunschweig, Ulrich, Wu, Mingkun, Gingras, Anne-Claude, Blencowe, Benjamin J. . Systematic analysis of alternative exon-dependent interactome remodeling reveals multitasking functions of gene regulatory factors. In Molecular cell, 83, 4222-4238.e10. doi:10.1016/j.molcel.2023.10.034. https://pubmed.ncbi.nlm.nih.gov/38065061/
4. An, Mingjie, Zheng, Hanhao, Huang, Jian, Chen, Changhao, Lin, Tianxin. . Aberrant Nuclear Export of circNCOR1 Underlies SMAD7-Mediated Lymph Node Metastasis of Bladder Cancer. In Cancer research, 82, 2239-2253. doi:10.1158/0008-5472.CAN-21-4349. https://pubmed.ncbi.nlm.nih.gov/35395674/
5. Hirano, Minato, Galarza-Muñoz, Gaddiel, Nagasawa, Chloe, Bradrick, Shelton, Garcia-Blanco, Mariano A. 2023. The RNA helicase DDX39B activates FOXP3 RNA splicing to control T regulatory cell fate. In eLife, 12, . doi:10.7554/eLife.76927. https://pubmed.ncbi.nlm.nih.gov/37261960/
6. Xu, Zhanzhan, Li, Xiaoman, Li, Hanxiao, Wang, Weibin, Wang, Jiadong. 2020. Suppression of DDX39B sensitizes ovarian cancer cells to DNA-damaging chemotherapeutic agents via destabilizing BRCA1 mRNA. In Oncogene, 39, 7051-7062. doi:10.1038/s41388-020-01482-x. https://pubmed.ncbi.nlm.nih.gov/32989256/
7. Banerjee, Shefali, Nagasawa, Chloe K, Widen, Steven G, Garcia-Blanco, Mariano A. . Parsing the roles of DExD-box proteins DDX39A and DDX39B in alternative RNA splicing. In Nucleic acids research, 52, 8534-8551. doi:10.1093/nar/gkae431. https://pubmed.ncbi.nlm.nih.gov/38801080/
8. Feng, Tianyu, Li, Siqi, Zhao, Gang, Li, Kai, Lin, Ping. 2023. DDX39B facilitates the malignant progression of hepatocellular carcinoma via activation of SREBP1-mediated de novo lipid synthesis. In Cellular oncology (Dordrecht, Netherlands), 46, 1235-1252. doi:10.1007/s13402-023-00807-8. https://pubmed.ncbi.nlm.nih.gov/37052853/
9. Wei, Jinhuan, Lu, Jun, Cao, Yun, Luo, Junhang, Cao, Jiazheng. . DDX39B Predicts Poor Survival and Associated with Clinical Benefit of Anti-PD-L1 Therapy in ccRCC. In Current cancer drug targets, 21, 849-859. doi:10.2174/1568009621666210811115054. https://pubmed.ncbi.nlm.nih.gov/34382524/
智鼠故事 
